An interview article with our company's Representative Director and CEO, Shunichi Kashida, was featured in the CiRA Newsletter Vol.51. In the article, Kashida discusses the reasons behind starting his own business and the significance of researchers becoming entrepreneurs.
Click here for related Links (CiRA Newsletter)
About xFOREST Therapeutics
xFOREST Therapeutics Co., Ltd. is a Kyoto-based RNA-targeted small molecule company. Building on its proprietary RNA structure analysis technology, xFOREST discovers selective small molecules for RNA targets that protein-first discovery cannot reach, and advances them into drug programs with partners.